Press release: Now Offering Aquablation Therapy for BPH

MidLantic Urology Now Offering Aquablation Therapy for BPH

Philadelphia, PA (August 22, 2023) – MidLantic Urology’s Dean Laganosky, MD now is offering Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) or enlarged prostate. Aquablation is a minimally invasive, robotic-assisted treatment option for BPH, a non-cancerous condition that affects half of men ages 51 to 60.

Aquablation therapy is an in-hospital procedure using the AquaBeam Robotic System, the first surgical robot the FDA has cleared to treat LUTS due to BPH. It combines imaging, automated robotic technology and heat-free waterjet technology for targeted, controlled and immediate removal of prostate tissue.

Dr. Laganosky specializes in treating enlarged prostates and says, “Aquablation is a safe, effective alternative to treating BPH, even for those with a very large prostate size. It uses the power of water delivered with robotic precision to provide long-lasting symptom relief with low rates of irreversible complications.”

BPH symptoms in men include:

• Frequent or urgent need to urinate, including increased nighttime urination
• Difficulty starting urination
• Weak urine stream or a stream that stops and starts
• Dribbling after urination
• Inability to empty the bladder completely

The incidence of BPH increases with every decade of life and if left untreated, can cause significant health problems, including irreversible bladder or kidney damage, bladder stones and incontinence.

“Unlike other BPH treatments, Aquablation provides patients, even those with very large prostates, relief from their symptoms and an improved quality of life without the fear of complications,” says Dr. Laganosky.

To learn more, or to schedule a consultation with Dr. Laganosky, visit www.MidLanticUrology.com